Last reviewed · How we verify

NCT03766828

Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion

Completed Last updated 29 May 2019
What this trial tests

trial testing inside-out-access technique with inside-out access device (Surfacer (R)) in Central Venous Catheter Thrombosis in 36 participants. Completed in 30 June 2018.

Timeline
1 September 2016
Primary endpoint
30 June 2018
30 June 2018

Quick facts

Lead sponsorMedical University of Vienna
StatusCompleted
Study typeOBSERVATIONAL
Enrollment36
Start date1 September 2016
Primary completion30 June 2018
Estimated completion30 June 2018
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

Medical University of Vienna

Who can join

Adults 18 to 80, any sex, with Central Venous Catheter Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A unique inside-out-access technique with a new CE certified device (Surfacer (R) Bluegrass Vascular, San Antonio, Tx, USA) enables repetitive and confident right-sided placement of central venous catheters in hemodialysis patients with thoracic central venous occlusion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Medical University of Vienna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03766828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing